Jeffrey Farrow Insider Profile
4 Followers
Jeffrey Farrow, CFO at Hyperion Therapeutics, holds 56.80K shares in Tarsus Pharmaceuticals (Ticker: TARS), holds 26.74K shares in Global Blood Therapeutics (Ticker: GBT), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-11.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Farrow holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Farrow
Jeffrey Farrow's Trading History
Hyperion Therapeutics
May 07, 2015
―
Uninformative Sell
6.64M
―
Global Blood Therapeutics
Jul 15, 2020
―
Uninformative Sell
1.14M
$1.83M
Tarsus Pharmaceuticals
Jun 17, 2026
CFO and Chief Strategy Officer
Uninformative Buy
834.05K
$3.59M
Achieve Life Sciences
―
Director
―
―
ZS Pharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Farrow's performance on stock
You May Also Like
Jeffrey Farrow insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Farrow?
The percentage of profitable transactions made by Jeffrey Farrow is 50%.
What is the average return per transaction made by Jeffrey Farrow?
The average return per transaction made by Jeffrey Farrow is -11.00%.
What stocks does Jeffrey Farrow hold?
Jeffrey Farrow holds: HPTX, GBT, TARS, ACHV, ZSPH stocks.
What was Jeffrey Farrow’s latest transaction?
Jeffrey Farrow latest transaction was an Uninformative Buy of $834.05K.
What was Jeffrey Farrow's most profitable transaction?
Jeffrey Farrow’s most profitable transaction was an Informative Sell of TARS stock on March 19, 2026. The return on the trade was 7.10%.
What is Jeffrey Farrow's role in Hyperion Therapeutics?
Jeffrey Farrow's role in Hyperion Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.